Jesse Kesner is a second-year MBA candidate at Harvard Business School and the Co-Founder and CEO of Alnu Health. At Alnu, Jesse developed the first clinically backed AI companion to support personalized lifestyle intervention for patients on GLP-1 therapy alongside clinical advisors from Mass General Brigham. Prior to business school, Jesse was an Associate at L Catterton, where he was on the Global Opportunities Team leading cross-fund global consumer sector investments and strategic initiatives. Previously, he served as a Senior Business Analyst at McKinsey & Company, where he specialized in Consumer Health and Private Equity, including completing a secondment to Peloton’s strategy team. Jesse graduated from the World Bachelor in Business program across USC, Hong Kong University of Science and Technology, and Bocconi University. In his free time, he enjoys cycling, skiing, and improv comedy.
